The New York-based company's AI platform integrates over 30 types of data to predict potential therapeutics and identify mechanisms driving efficacy, leading to increased accuracy and interpretability. Founded in 2018, OneThree Biotech optimizes compounds for toxicity or efficacy, generating new testable insights and hypotheses for novel targets, compounds, and combinations that could lead to new treatments for patients in need.